Publications
- Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Genetic testing in ovarian cancer2022 | First Faculty of Medicine
- Další geny s rizikem vzniku nádorů prsu a ovarií2022 | First Faculty of Medicine
- Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance2019 | First Faculty of Medicine
- Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic2019 | First Faculty of Medicine
- PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic2016 | First Faculty of Medicine
- CZECANCA: CZEch CAncer paNel for Clinical Application - Design and Optimization of the Targeted Sequencing Panel for the Identification of Cancer Susceptibility in High-risk Individuals from the Czech Republi2016 | First Faculty of Medicine
- The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic2012 | First Faculty of Medicine
- Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma2023 | First Faculty of Medicine, Central Library of Charles University, Faculty of Science
- Germline multigene panel testing of patients with endometrial cancer2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Science
Loading network view...